<DOC>
	<DOCNO>NCT00984633</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , pharmacokinetics , safety Org 9426 maintenance muscle relaxation adult subject undergo general elective surgery .</brief_summary>
	<brief_title>Study Efficacy , Pharmacokinetics , Safety Bolus Maintenance Doses Org 9426 ( Study P05976 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Subjects least 20 65 year age . Subjects asa class 1 , 2 3 general elective surgery . Subjects consider pregnant . Subjects schedule elective surgery sevoflurane propofol anesthesia , anticipate duration surgery 1.53 hour . Subjects normal laboratory value serum electrolyte ( Na+ , K+ , Cl ) , BUN , creatinine , total bilirubin , ALP , ALAT ASAT judge investigator subinvestigator . Subjects received explanation trial agree informed consent write participate trial advance . Subjects renal dysfunction complication history . Subjects serum creatinine level great 1.6 mg/dL . Subjects severe hepatic dysfunction complication history . Subjects know significant metabolic neuromuscular disorder . Subjects show dyspnea , airway obstruction bronchial asthma . Subjects history hypersensitivity pancuronium bromide , vecuronium bromide bromine . Subjects atopic disease . Subjects develop systemic allergic symptom . Subjects receive antihistamine antiallergic agent 1 month . Subjects receive follow drug know affect action neuromuscular blocking agent surgery day : calcium antagonist ; anticonvulsant ; aminoglycoside antibiotic ; polypeptide antibiotic ; metronidazole . Subjects hypothermic anesthesia . Subjects participate research subject another trial within last 6 month participate trial . Other subject judge ineligible subject trial discretion investigator subinvestigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Neuromuscular Blocking Agents</keyword>
</DOC>